GLP-1 Drugs Show Promise in Reducing Risk of Heart Attacks and Strokes

Scientists have discovered that GLP-1 based medications, such as Ozempic, Wegovy, and Mounjaro, significantly reduce the risk of cardiovascular events like heart attacks and strokes, in addition to their known benefits for diabetes and obesity.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

jutarnji-listSerbian94d ago

Znanstvenici došli do velikog otkrića: ‘Ovi lijekovi značajno smanjuju rizik od srčanih i moždanih udara‘

Osim što su se pokazali kao učinkoviti u borbi protiv dijabetesa i pretilosti, lijekovi zasnovani na GLP-1 (glukagonu sličnog peptida-1), kao što su Ozempic, Wegovy, Mounjaro i drugi, uvelike mogu pomoći i u prevenciji kardiovaskularnih oboljenja, pokazala je studija britanskih znanstvenika objavlje...

Read full article →

PERSPECTA

PERSPECTA

GLP-1 Drugs Show Promise in Reducing Risk of Heart Attacks and Strokes

Sources

Znanstvenici došli do velikog otkrića: ‘Ovi lijekovi značajno smanjuju rizik od srčanih i moždanih udara‘

Related Stories

HSE Agrees to Fund Friedreich's Ataxia Drug in Ireland

No West Nile Virus Cases Reported in FBiH, Public Health Director Urges Preparedness

Critical Heat Measurements in Vienna Senior Apartments Prompt Calls for Subsidized Air Conditioning

New Study Reveals High CTE Prevalence in Deceased NFL Players

PERSPECTA